Compare FRPT & INSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FRPT | INSP |
|---|---|---|
| Founded | 2004 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Medical/Dental Instruments |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 2.2B |
| IPO Year | 2014 | 2018 |
| Metric | FRPT | INSP |
|---|---|---|
| Price | $64.25 | $70.95 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 18 | 18 |
| Target Price | ★ $83.50 | $68.00 |
| AVG Volume (30 Days) | ★ 941.6K | 675.8K |
| Earning Date | 11-04-2026 | 11-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 183.87 | 179.43 |
| EPS | ★ 1.29 | N/A |
| Revenue | ★ $1,102,015,000.00 | $82,050,000.00 |
| Revenue This Year | $11.17 | N/A |
| Revenue Next Year | $8.52 | $3.91 |
| P/E Ratio | $52.18 | ★ N/A |
| Revenue Growth | 13.01 | ★ 62.18 |
| 52 Week Low | $46.45 | $38.91 |
| 52 Week High | $86.00 | $147.03 |
| Indicator | FRPT | INSP |
|---|---|---|
| Relative Strength Index (RSI) | 49.87 | 53.67 |
| Support Level | $56.79 | $67.10 |
| Resistance Level | $68.77 | $72.46 |
| Average True Range (ATR) | 2.67 | 2.63 |
| MACD | 0.24 | 0.01 |
| Stochastic Oscillator | 43.90 | 67.38 |
Freshpet produces and sells premium fresh pet food through its company-owned refrigerators placed in grocery, mass and club, pet specialty, and natural stores. Freshpet primarily targets dogs (likely representing well north of 90% of sales), with cats and treats nascent contributors. Geographically, the company's home US market, where all its food is produced, accounts for nearly all of sales, with exports to Canada, the United Kingdom, and other European countries being very small contributors.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region.